Physician profile

Michael Bickell

Urology · Langhorne, PA

NPI 1285947671

$8,170.74

in general payments reported to CMS, 2019-2025

48 companies · $946 in 2025

The $946 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,988.77

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,838.40 2019-2025 Lithovue, Ams 700, Amplatz Super Stiff
Coloplast Corp $999.05 2019-2024 Titan, Altis, Stenostent
Antares Pharma, INC. $679.18 2019-2025 Xyosted, Tlando, Nocdurna
Astellas Pharma US INC $528.29 2019-2024 Veozah, Myrbetriq, Xtandi
Aytu Biopharma, INC. $492.18 2019-2020
Medtronic, INC. $423.32 2021-2025 Interstim, Intellis Adaptivestim
Endo Pharmaceuticals INC. $402.11 2019-2023 Xiaflex, Aveed
Laborie Medical Technologies Corp. $256.18 2023-2025 Optilume Bph Drug Coated Balloon Catheter
Procept Biorobotics Corporation $254.92 2021-2025 Aquabeam System
Olympus America INC. $205.84 2023-2025 Soltive, Itind System, Bovie
Sumitomo Pharma America, INC. $192.19 2023-2025 Gemtesa, Orgovyx
Medtronic USA, INC. $173.28 2019-2020
Neotract INC. $156.05 2019-2020
Acerus Pharmaceuticals Corporation $125.85 2020-2022
Photocure INC $121.61 2020-2025 Cysview
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Baxter Healthcare $97.03 2023-2024 Perclot, Floseal
Convatec INC. $89.14 2022-2023
Amgen INC. $72.47 2019-2020
Urovant Sciences INC $70.69 2021-2022
Endo USA, INC. $67.56 2024-2025 Xiaflex, Aveed
Ferring Pharmaceuticals INC. $64.06 2024 Adstiladrin
Rochester Medical Corporation $58.76 2019-2022
Axonics, INC. $58.38 2022-2024 Bulkamid, Axonics
Mission Pharmacal Company $49.52 2022-2024 Uribel Tabs
Calyxo, INC. $49.34 2024-2025 Cvac Aspiration System
Novo Nordisk INC $47.93 2025 Rivfloza
Janssen Biotech, INC. $43.78 2025 Erleada
Bluewind Medical $40.26 2024 Revi
Avadel Specialty Pharmaceuticals, LLC $38.01 2019
Halozyme INC $37.61 2023
Novartis Pharmaceuticals Corporation $35.39 2024-2025
Urogen Pharma, INC. $35.35 2022
Pfizer INC. $34.60 2019-2024
Abbvie INC. $31.40 2024-2025
Integra Lifesciences Corporation $31.26 2024 Integra, Integra Dermal Regeneration Template, Primatrix
Abc Home Medical Supply, INC. $28.59 2025
180 Medical, INC. $27.41 2025
Foundation Medicine, INC. $26.23 2022
Bioprotect Medical, INC. $23.18 2025 Bioprotect Balloon Implant System
Blue Earth Diagnostics $21.83 2023
Bayer Healthcare Pharmaceuticals INC. $19.89 2019
Clarus Therapeutics INC. $19.74 2021
Tolmar Pharmaceuticals, INC. $18.80 2019
Valencia Technologies Corporation $18.37 2025 Ecoin Device Kit
Telix Pharmaceuticals $18.11 2023 Illuccix
Vertex Pharmaceuticals Incorporated $16.11 2024
Allergan, INC. $16.03 2019
Merck Sharp & Dohme LLC $15.46 2024 Keytruda

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Bickell

$8,170.74

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $946 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/1027131/michael-bickell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.